RID has always maintained a tradition of developing successful partnerships with reputed parties all over the world, in addition to its own development projects. RID welcomes the US, Japanese and European companies to partner with us and cash in on a mutual beneficial and fruitful business opportunities and forges broadpartnerships to develop, register and commercialize their products in our health ministry (Out- Lenience). Rising the confidence in our financial management and our capital resource encourage us to press ahead on a normalization path that consequently has helped us drive up yields in the mutual business. Our Investors no longer need to take on as much risk to generate enough return on their fiscal budgets. Our Investors have piled into safest business in our organization for search of higher their yields and their remarkable dividends.
We are actively evaluating potential (Out-licensing) opportunities for Generic and innovative products, where significant unmet medical need exists or in subset patient populations where the compound may have significant promise.
If you are interested in learning more about collaboration opportunities with RID, or to discuss a compound currently in clinical development, please contact our business development team via email at: firstname.lastname@example.org
Apotex believes that every man, woman and child is entitled to affordable medical care and freedom from pain and suffering. For over 35 years, Apotex has met the healthcare challenges of tomorrow and fought hard to build a successful worldwide pharmaceutical company. Through a strategy of vertical integration, Apotex has built an exceptional scientific and manufacturing base that supports a global sales and marketing infrastructure. We have done this with the objective of Advancing Generics. Apotex is focused on meeting the world's long-term need for quality, affordable medicines. We have built the facilities, the scientific R&D base, and the technology to meet the healthcare needs of the world for today
Biocodex specializes in manufacturing and fabrication of pharmaceutical drugs. The Company provides products and services for therapeutic areas which includes gastroenterology, pain management, neurology, psychiatry, and otalaryngology. Biocodex serves customers worldwide.
Many of our children are enzyme deficient,” writes Elizabeth Lipski, Ph.D., C.C.N., a board-certified clinical nutritionist in her book, Digestive Wellness for Children. “These deficiencies can play a pivotal role in the development of childhood disease.”Lipski has over 20 years’ experience working in the field of holistic and complementary medicine and views enzymes as the body’s workhorses.
“In the adolescent and elder patients (enzyme supplements) have been used successfully to treat food allergies, cardiovascular disease, gastroenteritis, asthma, and other illnesses, and research on enzymes is promising.
Like healthy bones and muscle tissue, our enzyme producing organs rely on good nutrition to fuel production. Physical stressors and inflammation are also implicated as a component in compromised enzyme capacity, and these conditions are common with autism.
The ERG researchers found a statistically significant 80% of autistic children experience digestive disturbances related to certain types of food, with dairy topping the list. 57% said dairy is the culprit, and wheat was second in line with 43%.
We are proud to be exclusive Distributor of enzyme supplements with focusing on establishing and managing EU, UK and US based companies in our organization which manufacture healthy therapeutic supplements. We are delighted to have the opportunity to offer a growing number of consumers this range of innovative enzyme products”.